148 related articles for article (PubMed ID: 30158896)
1. Anti-ARHGAP26 Autoantibodies Are Associated With Isolated Cognitive Impairment.
Bartels F; Prüss H; Finke C
Front Neurol; 2018; 9():656. PubMed ID: 30158896
[TBL] [Abstract][Full Text] [Related]
2. Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline.
Doss S; Nümann A; Ziegler A; Siebert E; Borowski K; Stöcker W; Prüss H; Wildemann B; Endres M; Jarius S
J Neuroimmunol; 2014 Feb; 267(1-2):102-4. PubMed ID: 24439423
[TBL] [Abstract][Full Text] [Related]
3. Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia.
Jarius S; Martínez-García P; Hernandez AL; Brase JC; Borowski K; Regula JU; Meinck HM; Stöcker W; Wildemann B; Wandinger KP
J Neuroinflammation; 2013 Jan; 10():7. PubMed ID: 23320754
[TBL] [Abstract][Full Text] [Related]
4. From dizziness to severe ataxia and dysarthria: New cases of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum.
Wallwitz U; Brock S; Schunck A; Wildemann B; Jarius S; Hoffmann F
J Neuroimmunol; 2017 Aug; 309():77-81. PubMed ID: 28601293
[TBL] [Abstract][Full Text] [Related]
5. Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis.
Jarius S; Komorowski L; Regula JU; Haas J; Brakopp S; Wildemann B
J Neurol; 2022 Oct; 269(10):5420-5430. PubMed ID: 35624318
[TBL] [Abstract][Full Text] [Related]
6. Psychotic syndrome associated with anti-Ca/ARHGAP26 and voltage-gated potassium channel antibodies.
Jarius S; Wildemann B; Stöcker W; Moser A; Wandinger KP
J Neuroimmunol; 2015 Sep; 286():79-82. PubMed ID: 26298328
[TBL] [Abstract][Full Text] [Related]
7. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.
Jarius S; Scharf M; Begemann N; Stöcker W; Probst C; Serysheva II; Nagel S; Graus F; Psimaras D; Wildemann B; Komorowski L
J Neuroinflammation; 2014 Dec; 11():206. PubMed ID: 25498830
[TBL] [Abstract][Full Text] [Related]
9. A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.
Jarius S; Wandinger KP; Horn S; Heuer H; Wildemann B
J Neuroinflammation; 2010 Mar; 7():21. PubMed ID: 20226058
[TBL] [Abstract][Full Text] [Related]
10. GTPase Regulator Associated with Focal Adhesion Kinase 1 (GRAF1) Immunoglobulin-Associated Ataxia and Neuropathy.
Pittock SJ; Alfugham N; O'Connor K; Hinson S; Kunchok A; Lennon VA; Komorowski L; Probst C; McKeon A
Mov Disord Clin Pract; 2020 Nov; 7(8):904-909. PubMed ID: 33163561
[TBL] [Abstract][Full Text] [Related]
11. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
[TBL] [Abstract][Full Text] [Related]
12. Neuronal autoantibodies associated with cognitive impairment in melanoma patients.
Bartels F; Strönisch T; Farmer K; Rentzsch K; Kiecker F; Finke C
Ann Oncol; 2019 May; 30(5):823-829. PubMed ID: 30840061
[TBL] [Abstract][Full Text] [Related]
13. Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis.
Jarius S; Haas J; Wildemann B
J Neurol; 2023 Mar; 270(3):1776-1780. PubMed ID: 36333454
[No Abstract] [Full Text] [Related]
14. High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients.
Finke C; Bartels F; Lütt A; Prüss H; Harms L
J Neurol; 2017 Sep; 264(9):1968-1977. PubMed ID: 28785798
[TBL] [Abstract][Full Text] [Related]
15. 'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():166. PubMed ID: 26377085
[TBL] [Abstract][Full Text] [Related]
16. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.
Franke C; Boesl F; Goereci Y; Gerhard A; Schweitzer F; Schroeder M; Foverskov-Rasmussen H; Heine J; Quitschau A; Kandil FI; Schild AK; Finke C; Audebert HJ; Endres M; Warnke C; Prüss H
Brain Behav Immun; 2023 Mar; 109():139-143. PubMed ID: 36657623
[TBL] [Abstract][Full Text] [Related]
17. Untreated anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia progressing over 27 years.
Schegk E; Beiser I; Achtnichts L; Nedeltchev K; Bertschi M; Gschwind M
J Neurol; 2023 Jun; 270(6):3258-3260. PubMed ID: 36856845
[No Abstract] [Full Text] [Related]
18. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
19. Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy.
Jarius S; Ringelstein M; Haas J; Serysheva II; Komorowski L; Fechner K; Wandinger KP; Albrecht P; Hefter H; Moser A; Neuen-Jacob E; Hartung HP; Wildemann B; Aktas O
J Neuroinflammation; 2016 Oct; 13(1):278. PubMed ID: 27776522
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
